Cargando…
Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
OBJECTIVE: We aimed to analyze clinical outcomes from patients with severe COVID-19 pneumonia that received either baricitinib plus dexamethasone or dexamethasone monotherapy. METHODOLOGY: We performed a retrospective comparative study. Data from hospitalized patients with severe COVID-19 pneumonia...
Autores principales: | Pérez-Alba, Eduardo, Nuzzolo-Shihadeh, Laura, Aguirre-García, Gloria Mayela, Espinosa-Mora, Jaime, Lecona-Garcia, Juan Diego, Flores-Pérez, Romulo Omar, Mendoza-Garza, Marisela, Camacho-Ortiz, Adrián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253716/ https://www.ncbi.nlm.nih.gov/pubmed/34294593 http://dx.doi.org/10.1016/j.jmii.2021.05.009 |
Ejemplares similares
-
Use of self-administered surveys through QR code and same center telemedicine in a walk-in clinic in the era of COVID-19
por: Perez-Alba, Eduardo, et al.
Publicado: (2020) -
Frequency of facial touching in patients with suspected COVID-19 during their time in the waiting room
por: Perez-Alba, Eduardo, et al.
Publicado: (2020) -
A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022) -
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018) -
Hospitalization and risk of death due to influenza among vaccinated and unvaccinated patients. A 5-year study in the northeastern Mexican population
por: Nuzzolo-Shihadeh, Laura, et al.
Publicado: (2022)